PTEO — Proteo Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareMicro Cap
Annual cashflow statement for Proteo, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2015 December 31st | C2016 December 31st | C2017 December 31st | 2018 December 31st | 2019 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -0.312 | -0.034 | -0.145 | 0.039 | -0.221 |
| Depreciation | |||||
| Non-Cash Items | -0.129 | -0.051 | 0.083 | -0.03 | -0.013 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.036 | -0.027 | -0.025 | -0.13 | 0.005 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -0.472 | -0.109 | -0.085 | -0.119 | -0.228 |
| Capital Expenditures | -0.001 | 0 | -0.002 | 0 | — |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0 | — | — | — | — |
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.001 | 0 | -0.002 | 0 | — |
| Financing Cash Flow Items | — | 0.016 | 0.041 | 0.003 | 0 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Cash from Financing Activities | — | 0.016 | 0.041 | 0.103 | 0.242 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.545 | -0.096 | -0.028 | -0.025 | 0.01 |